Browsing: Candidate

Cancer immunotherapy, which promotes the body’s immune system to fight tumors, has historically focused on utilizing the natural capacity of…

Insilico Medicine (“Insilico”), a clinical-stage genetic artificial intelligence (AI) drug discovery company, successfully delivered its second preclinical compound candidate (PCC)…